Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVRd in Newly Diagnosed Multiple Myeloma With Extramedullary Disease
NCT05900882Phase 2Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jul 2022
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in multiple myeloma (MM), sponsored by Jiangsu Provincial People's Hospital. Started Jul 2022; status: completed.
02
Drugs
selinexor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT05900882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05900882.